Covid-Cancer Huil Study: Registry Of Oncologic Patients Diagnosed With Covid-19 In Infanta Leonor University Hospital In Madrid, Spain.

Background: Covid-19 has been shown to present more complications in immunosuppressed patients. We determine whether differences exist in Covid-19-related mortality between cancer patients and general population in our hospital, and we also describe associated risk factors. Methods: We reviewed 2,216 medical records of all patients admitted to hospitalization in Infanta Leonor University Hospital in Madrid, Spain, with Covid-19 diagnosis between 5 March and 13 May, 2020. Study data were collected and managed using REDCap electronic data capture tools. We described Covid-19 cumulative incidence in cancer patients, treatment outcome, mortality, and associated risk factors. Results: We detected 85/2,216 cancer patients between all Covid-19 diagnoses. Mortality rate: 40/85 cancer patients vs. 260/2,131 in general ward (p Conclusions: Covid-19 had a significant mortality in cancer patients. High D dimer and LDH levels and ARDS development in elderly metastatic patients carry an elevated risk of death in cancer patients diagnosed with Covid-19. However, only 2/85 patients were admitted to ICU and these data were decisive. It is a priority to create measures to avoid Covid-19 transmission in oncologic patients. Citation Format: Jacobo Rogado, Berta Obispo, Gloria Serrano-Montero, Almudena Martin Merino, Ana Lopez-Alfonso, Cristina Pangua, Mar Perez-Perez, Mario Fontan-Vela, Miguel Angel Lara. COVID-CANCER HUIL STUDY: Registry of oncologic patients diagnosed with Covid-19 in Infanta Leonor University Hospital in Madrid, Spain [abstract]. In: Proceedings of the AACR Virtual Meeting: COVID-19 and Cancer; 2020 Jul 20-22. Philadelphia (PA): AACR; Clin Cancer Res 2020;26(18_Suppl):Abstract nr PO-060.